Immunomodulatory Activity of Lipopolysaccharide LPS Isolated From ECOLI

Abstract

Lipopolysaccharide (LPS), a major component of the outer membrane of Gram-negative bacteria such as Escherichia coli, plays a significant role in modulating the host immune response. The present study investigates the immunomodulatory activity of LPS isolated from E. coli and its effects on immune cell activation. LPS was extracted and purified using standard isolation techniques and characterized through biochemical analysis. The immunomodulatory potential of the isolated LPS was evaluated by assessing its ability to stimulate cytokine production, macrophage activation, and lymphocyte proliferation. Experimental results demonstrated that LPS significantly enhanced the secretion of pro-inflammatory cytokines, including tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and interleukin-1 beta (IL-1β), indicating activation of innate immune responses. Furthermore, LPS treatment promoted macrophage phagocytic activity and induced the expression of immune-related surface markers. The interaction of LPS with Toll-like receptor 4 (TLR4) triggered intracellular signaling pathways, leading to the activation of nuclear factor-kappa B (NF-κB) and subsequent immune regulation. These findings suggest that E. coli-derived LPS possesses potent immunostimulatory properties and can effectively modulate both innate and adaptive immune responses. The study highlights the importance of bacterial LPS as a valuable tool for understanding host-pathogen interactions and its potential application in vaccine adjuvant development and immunotherapeutic strategies.